Norimoto Hisayoshi
Chief Executive Officer at PuraPharm Japan Corp.
Net worth: 39 239 $ as of 2024-03-30
Profile
Norimoto Hisayoshi is currently the Chief Executive Officer at PuraPharm Japan Corp.
and also holds a position as General Manager at Sodx Co., Ltd.
His former positions include Executive Director at PuraPharm Corp.
Ltd., Head of Research & Development at Kracie Pharma Ltd.
and Kracie Pharmaceutical Ltd., Chief Research & Development Officer & GM at PuraPharm Corp.
Ltd., and General Manager at PuraPharm Japan Corp.
His education includes a doctorate and graduate degree from the University of Toyama.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PURAPHARM CORP. LTD.
0.09% | 2022-12-30 | 370,000 ( 0.09% ) | 39 239 $ | 2024-03-30 |
Norimoto Hisayoshi active positions
| Companies | Position | Start |
|---|---|---|
Sodx Co., Ltd.
 Sodx Co., Ltd. Food RetailRetail Trade Part of PuraPharm Corp. Ltd., Sodx Co., Ltd. is a Japanese real estate company that specializes in condominium management and asset management. The company promises a safe and rich future that does not rely on public pensions through valuable real estate. The company aims to provide attractive condominiums with high asset value to realize a relaxed life. Sodx Co. was acquired by PuraPharm Corp. Ltd. on August 28, 2017 for $2.24 million. | Corporate Officer/Principal | - |
| PuraPharm Japan Corp. | Chief Executive Officer | 2023-11-19 |
Former positions of Norimoto Hisayoshi
| Companies | Position | End |
|---|---|---|
| PURAPHARM CORPORATION LIMITED | Director/Board Member | 2023-11-19 |
| Kracie Pharmaceutical Ltd. | Chief Tech/Sci/R&D Officer | 2015-12-31 |
Kracie Pharma Ltd.
 Kracie Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kracie Pharma Ltd. engages in the research and development of pharmaceutical products. It specializes in the manufacture and sale of kampo medicines and other related medicines for hospitals. The company was founded on May 1, 2006 and is headquartered in Tokyo, Japan. | Chief Tech/Sci/R&D Officer | 2005-12-31 |
| PuraPharm Japan Corp. | Corporate Officer/Principal | - |
| PURAPHARM CORPORATION LIMITED | Chief Tech/Sci/R&D Officer | - |
Training of Norimoto Hisayoshi
| University of Toyama | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PURAPHARM CORPORATION LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Kracie Pharma Ltd.
Kracie Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kracie Pharma Ltd. engages in the research and development of pharmaceutical products. It specializes in the manufacture and sale of kampo medicines and other related medicines for hospitals. The company was founded on May 1, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
| Kracie Pharmaceutical Ltd. | |
Sodx Co., Ltd.
Sodx Co., Ltd. Food RetailRetail Trade Part of PuraPharm Corp. Ltd., Sodx Co., Ltd. is a Japanese real estate company that specializes in condominium management and asset management. The company promises a safe and rich future that does not rely on public pensions through valuable real estate. The company aims to provide attractive condominiums with high asset value to realize a relaxed life. Sodx Co. was acquired by PuraPharm Corp. Ltd. on August 28, 2017 for $2.24 million. | Retail Trade |
| PuraPharm Japan Corp. |
- Stock Market
- Insiders
- Norimoto Hisayoshi
